Prognostic analysis using GEPIA indicated that high PDCL3 expression correlated with worse prognosis in various cancer types, including ACC, KICH, LGG, LUAD, LIHC, MESO, and UVM (Fig. 1C). This evidence concerns the gene PDCL3 and cancer.